Skip to main content

International Commission on the Clinical Use of Human Germline Genome Editing

Completed

An international commission has been convened by the U.S. National Academy of Medicine, the U.S. National Academy of Sciences, and the U.K.’s Royal Society, with the participation of academies of sciences and medicine from around the world. The commission will develop a framework for scientists, clinicians, and regulatory authorities to consider when assessing potential clinical applications of human germline genome editing, should society conclude that heritable human genome editing applications are acceptable.

Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.